Publications by authors named "Philip He"

Claim this Profile
T
The necessity of motoric engagement in enhancing route memory.
Yadurshana Sivashankar, Philip He, Patrick Tsapoitis, Evan Skorski, Myra A Fernandes

Br J Psychol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring Quality and Interpretability of Progression Free Survival and Overall Survival in Oncology Clinical Trials.
Philip He, Haijun Ma, Chengxing Cindy Lu, Revathi Ananthakrishnan, Gu Mi

Ther Innov Regul Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian Basket Trial Design Using Local Power Prior.
Haiming Zhou, Rex Shen, Sutan Wu, Philip He

Biom J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan.
Philip He, Dhiraj Gambhire, Haiming Zhou, Xiaoyang Ma, Yoshihiro Emura

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian Hybrid Design With Borrowing From Historical Study.
Zhaohua Lu, John Toso, Girma Ayele, Philip He

Pharm Stat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Separation of Kaplan-Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis.
Do-Youn Oh, Nana Rokutanda, Magdalena Żotkiewicz, Philip He, Jennifer Stocks

Target Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Adaptive Seamless Clinical Trials for Late-Phase Oncology Development.
Kristine Broglio, Freda Cooner, Yujun Wu, Mike Xiao, X Q Xue, Philip He

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team.
Yingwen Dong, Gautier Paux, Kristine Broglio, Freda Cooner, Guozhi Gao, Wei He, Philip He

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer.
Alessandria Struebing, Chelsea McKibbon, Haoyao Ruan, Emma Mackay, Natalie Dennis, Philip He

J Comp Eff Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Philip He, Jagdish Shetty

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma.
Xuyang Song, Robin Kate Kelley, Anis A Khan, Nathan Standifer, Diansong Zhou, Philip He

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Ghassan K Abou-Alfa, George Lau, Masatoshi Kudo, Stephen L Chan, Robin Kate Kelley, Alexandra Heurgué, Satheesh Chiradoni Thungappa, Ann-Lii Cheng, Michelle Marcovitz, Philip He

NEJM Evid· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka, Jen-Shi Chen, Philip He, Gordon Cohen

NEJM Evid· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research productivity and impact of Canadian academic ophthalmologists: trends in H-index, gender, subspecialty, and faculty appointment.
Stuti M Tanya, Bonnie He, Janet Tang, Philip He, Angela Zhang

Can J Ophthalmol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Disparities in E-Cigarette Use among Conventionally Smoking Cancer Survivors in the United States, 2014-2018.
Hannah E Philip, David M Hein, Nina N Sanford

Subst Use Misuse· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Ann-Lii Cheng, Philip He

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A weighted log-rank test and associated effect estimator for cancer trials with delayed treatment effect.
Chang Yu, Xiang Huang, Hui Nian, Philip He

Pharm Stat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Thomas Powles, Michiel S van der Heijden, Daniel Castellano, Matthew D Galsky, Yohann Loriot, Som D Mukherjee, Philip He

Lancet Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis